Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of lymphocytic colitis.
Epistemonikos ID: 55128a8b82675f41d2647da930f0b65e150bea54
First added on: May 05, 2024